Open AI’s Sam Altman Is Jumping Into Psychedelics. But Do We Need Him?
DoubleBlind
Tue, Oct 22
The founder of ChatGPT is working to get LSD and MDMA FDA-approved. But who benefits when tech billionaires drive mental health treatments?
Share your feedback with us
If you're passionate about plant medicine and excited by our mission, we'd love to hear your perspective on how we can best meet your needs.
Share Feedback Join our waitlist
Join our waitlist today to get ahead of the curve and become a part of this trailblazing community.
Join Today Share with friends
Invite your friends to be part of this trailblazing community revolutionizing mental health, physical wellbeing, and human consciousness.